Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cartilage acidic protein 1 (CRTAC1) is a glycosylated extracellular matrix protein expressed at high levels in the deeper zones of articular cartilage and in select regions of the brain. It contains four FG-GAP domains and one EGF-like domain, with an RGD integrin-binding motif in human protein, suggesting a role in cell adhesion and matrix interactions[2][5]. CRTAC1 forms part of the beta-propeller protein family and has a demonstrated propensity to form amyloid-like aggregates, which may be linked to disease association[1]. Alternative splicing produces isoforms with distinct functions, such as LOTUS, involved in neuronal growth cone regulation[2]. CRTAC1 is emerging as a plasma biomarker for osteoarthritis risk assessment and has been implicated in syndromic diseases including neurofibromatosis and pulmonary systemic sclerosis[3][5]. It is not currently a direct target for drugs but has diagnostic relevance.
Not directly targeted by drugs; potential mechanisms include modulation of cartilage matrix integrity and neuronal growth cone stabilization
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cartilage acidic protein 1 (CRTAC1).